製品名:(+/-)-Narwedine

IUPAC Name:(1S,12S)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0¹,¹².0⁶,¹⁷]heptadeca-6,8,10(17),15-tetraen-14-one

CAS番号:1668-86-6
分子式:C17H19NO3
純度:95%
カタログ番号:CM244272
分子量:285.34

包装単位 有効在庫 価格(USD) 数量
CM244272-250mg in stock ưư
CM244272-1g in stock ǵƓNJ
CM244272-5g in stock ưǤǵ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1668-86-6
分子式:C17H19NO3
融点:-
SMILESコード:O=C1C=C[C@@]23CCN(C)CC4=CC=C(OC)C(O[C@@]3([H])C1)=C24
密度:
カタログ番号:CM244272
分子量:285.34
沸点:
MDL番号:MFCD13193038
保管方法:

Column Infos

ZUNVEYL
Alpha Cognition announced that the FDA has granted approval for ZUNVEYL® (benzgalantamine) previously known as ALPHA-1062, for the treatment of mild-to-moderate Alzheimer’s disease. ZUNVEYL, a prodrug of AD treatment galantamine and an acetylcholinesterase inhibitor (AChEI), is postulated to exert its therapeutic effect by preventing the breakdown of acetylcholine, the important brain neurotransmitter involved in memory, motivation, and attention functions. The approval of ZUNVEYL is a pivotal moment in the fight against Alzheimer’s disease as it is only the second oral AD treatment to be approved in more than a decade.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products